Chicago [US], June 26 (ANI): According to a study presented at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, the percentage of adults with metabolic-associated fatty liver disease (MAFLD), the major global cause of liver disease, is growing. Mexican Americans consistently had the highest percentage of MAFLD, especially in…Read More
Study reveals prevalence of metabolically related fatty liver disease is rising
